NDC codes

FDA NDC Directory
Product NDC (as listed)80425-0131Labeler and product segments. Claims need a package NDC.
Product NDC at billing width80425-0131Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
80425-0131-28042501310260 TABLET in 1 BOTTLE (80425-0131-2)Marketed from Jun 19, 2017
80425-0131-38042501310390 TABLET in 1 BOTTLE (80425-0131-3)Marketed from Jun 19, 2017

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Metaxalone
Generic name (nonproprietary)
metaxalone
Active ingredients
Metaxalone — 800 mg/1
Dosage form
Tablet
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 203695
Marketing start
Listing expires
Other FDA classes
Centrally-mediated Muscle Relaxation (Physiologic effect)
Identifiers
Product ID 80425-0131_2a998081-6431-8228-e063-6294a90adc3dSPL ID 2a998081-6431-8228-e063-6294a90adc3dSPL set ID bd1c9022-aadc-af1f-e053-2995a90a0b42RxCUI 351254UNII 1NMA9J598Y
Pharmacologic class
Muscle Relaxant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N480425013102 followed by a unit qualifier and the quantity

Package 80425-0131-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

Indications and Usage Section INDICATIONS AND USAGE Metaxalone tablets are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions. The mode of action of this drug has not been clearly identified, but may be related to its sedative properties. Metaxalone does not directly relax tense skeletal muscles in man.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 203695

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203695
ProductStrengthForm · routeLabelerProduct NDC
MetaxaloneMetaxalone 800 mg/1TabletOralDirect_Rx72189-645
MetaxaloneMetaxalone 800 mg/1TabletOralProficient Rx LP71205-326
MetaxaloneMetaxalone 800 mg/1TabletOralSportpharm LLC85766-011
MetaxaloneMetaxalone 800 mg/1TabletOralBryant Ranch Prepack71335-0375
MetaxaloneMetaxalone 800 mg/1TabletOralPHOENIX RX LLC85509-2341
MetaxaloneMetaxalone 800 mg/1TabletOralSt. Mary's Medical Park Pharmacy60760-093
MetaxaloneMetaxalone 800 mg/1TabletOralBryant Ranch Prepack63629-8014
MetaxaloneMetaxalone 800 mg/1TabletOralAsclemed USA, Inc.76420-898
MetaxaloneMetaxalone 800 mg/1TabletOralDoc Rx69306-100
MetaxaloneMetaxalone 800 mg/1TabletOralActavis Pharma, Inc.0591-2341

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in